BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32282800)

  • 1. Potency and breadth of human primary ZIKV immune sera shows that Zika viruses cluster antigenically as a single serotype.
    Nix CD; Salberg J; Coulter FJ; Kareko BW; Lyski ZL; Booty BL; Messer WB
    PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008006. PubMed ID: 32282800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype.
    Dowd KA; DeMaso CR; Pelc RS; Speer SD; Smith ARY; Goo L; Platt DJ; Mascola JR; Graham BS; Mulligan MJ; Diamond MS; Ledgerwood JE; Pierson TC
    Cell Rep; 2016 Aug; 16(6):1485-1491. PubMed ID: 27481466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage.
    Marchi S; Dragoni F; Boccuto A; Idoko OT; Zazzi M; Sow S; Diallo A; Viviani S; Montomoli E; Vicenti I; Trombetta CM
    Acta Trop; 2023 Jan; 237():106736. PubMed ID: 36374844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. African-Lineage Zika Virus Replication Dynamics and Maternal-Fetal Interface Infection in Pregnant Rhesus Macaques.
    Crooks CM; Weiler AM; Rybarczyk SL; Bliss M; Jaeger AS; Murphy ME; Simmons HA; Mejia A; Fritsch MK; Hayes JM; Eickhoff JC; Mitzey AM; Razo E; Braun KM; Brown EA; Yamamoto K; Shepherd PM; Possell A; Weaver K; Antony KM; Morgan TK; Zeng X; Dudley DM; Peterson E; Schultz-Darken N; O'Connor DH; Mohr EL; Golos TG; Aliota MT; Friedrich TC
    J Virol; 2021 Jul; 95(16):e0222020. PubMed ID: 34076485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue immune sera enhance Zika virus infection in human peripheral blood monocytes through Fc gamma receptors.
    Li M; Zhao L; Zhang C; Wang X; Hong W; Sun J; Liu R; Yu L; Wang J; Zhang F; Jin X
    PLoS One; 2018; 13(7):e0200478. PubMed ID: 30044839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.
    Montoya M; Collins M; Dejnirattisai W; Katzelnick LC; Puerta-Guardo H; Jadi R; Schildhauer S; Supasa P; Vasanawathana S; Malasit P; Mongkolsapaya J; de Silva AD; Tissera H; Balmaseda A; Screaton G; de Silva AM; Harris E
    J Infect Dis; 2018 Jul; 218(4):536-545. PubMed ID: 29618091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An epidemiological survey of the current status of Zika and the immune interaction between dengue and Zika infection in Southern Taiwan.
    Wang WH; Urbina AN; Wu CC; Lin CY; Thitithanyanont A; Assavalapsakul W; Lu PL; Chen YH; Wang SF
    Int J Infect Dis; 2020 Apr; 93():151-159. PubMed ID: 31982624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-Reaction, Enhancement, and Neutralization Activity of Dengue Virus Antibodies against Zika Virus: A Study in the Mexican Population.
    Montecillo-Aguado MR; Montes-Gómez AE; García-Cordero J; Corzo-Gómez J; Vivanco-Cid H; Mellado-Sánchez G; Muñoz-Medina JE; Gutiérrez-Castañeda B; Santos-Argumedo L; González-Bonilla C; Cedillo-Barrón L
    J Immunol Res; 2019; 2019():7239347. PubMed ID: 31565661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice.
    Sapparapu G; Fernandez E; Kose N; Bin Cao ; Fox JM; Bombardi RG; Zhao H; Nelson CA; Bryan AL; Barnes T; Davidson E; Mysorekar IU; Fremont DH; Doranz BJ; Diamond MS; Crowe JE
    Nature; 2016 Dec; 540(7633):443-447. PubMed ID: 27819683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of Japanese encephalitis virus antibodies on Zika virus infection.
    He X; Lang X; Yu J; Zhu L; Qin Z; Liu X; Chen P; Dai C; Chen T; Li X; Chen Y; Zhou D; Fang W; Xiao W; Zhang B; Xie Q; Wu Q; Zhao W
    Med Microbiol Immunol; 2020 Apr; 209(2):177-188. PubMed ID: 32078028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterologous Protection against Asian Zika Virus Challenge in Rhesus Macaques.
    Aliota MT; Dudley DM; Newman CM; Mohr EL; Gellerup DD; Breitbach ME; Buechler CR; Rasheed MN; Mohns MS; Weiler AM; Barry GL; Weisgrau KL; Eudailey JA; Rakasz EG; Vosler LJ; Post J; Capuano S; Golos TG; Permar SR; Osorio JE; Friedrich TC; O'Connor SL; O'Connor DH
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005168. PubMed ID: 27911897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zika virus infection confers protection against West Nile virus challenge in mice.
    Vázquez-Calvo Á; Blázquez AB; Escribano-Romero E; Merino-Ramos T; Saiz JC; Martín-Acebes MA; Jiménez de Oya N
    Emerg Microbes Infect; 2017 Sep; 6(9):e81. PubMed ID: 28928416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of Zika virus infection by antibodies from West Nile virus seropositive individuals with no history of clinical infection.
    Garg H; Yeh R; Watts DM; Mehmetoglu-Gurbuz T; Resendes R; Parsons B; Gonzales F; Joshi A
    BMC Immunol; 2021 Jan; 22(1):5. PubMed ID: 33421988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection.
    Collins MH; McGowan E; Jadi R; Young E; Lopez CA; Baric RS; Lazear HM; de Silva AM
    Emerg Infect Dis; 2017 May; 23(5):773-781. PubMed ID: 28418292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
    Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
    mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey on neutralizing antibodies against Zika virus eighteen months post-outbreak in two southern Thailand communities.
    Densathaporn T; Sangthong R; Sakolnapa M; Surasombatpattana S; Kemapunmanus M; Masrinoul P; Yoksan S; McNeil EB; Chongsuvivatwong V
    BMC Infect Dis; 2020 Dec; 20(1):921. PubMed ID: 33272192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of viral entry for Asian and African lineages of Zika virus.
    Rinkenberger N; Schoggins JW
    Virology; 2019 Jul; 533():59-67. PubMed ID: 31112915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virus.
    Vang L; Morello CS; Mendy J; Thompson D; Manayani D; Guenther B; Julander J; Sanford D; Jain A; Patel A; Shabram P; Smith J; Alexander J
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009195. PubMed ID: 33711018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dengue virus envelope protein domain III-elicited antibodies mediate cross-protection against Zika virus in a mouse model.
    Zhou Y; Chen D; Yang L; Zou W; Duan Z; Zhang Y; Wen J
    Virus Res; 2020 Mar; 278():197882. PubMed ID: 31981774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Anti-Dengue and Anti-Zika IgG on a Plasmonic Gold Platform with Neutralization Testing.
    Rojas A; Natrajan MS; Weber J; Cardozo F; Cantero C; Ananta JS; Kost J; Tang M; López S; Bernal C; Guillén Y; Mendoza L; Páez M; Pinsky BA; Waggoner JJ
    Am J Trop Med Hyg; 2021 Mar; 104(5):1729-1733. PubMed ID: 33782214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.